Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06852001

Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

A Prospective, Multi-center, Single-Arm Study on the Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the efficacy of stereotactic radiotherapy in the treatment of brain metastases. The main question it aims to answer is: Did stereotactic radiotherapy improve LC rate in the treatment of brain metastases? Participants will be recorded for local control rates during follow-up.

Conditions

Interventions

TypeNameDescription
DEVICEX-ray stereotactic radiotherapy for brain metastasisX-ray stereotactic radiotherapy for brain metastasis

Timeline

Start date
2025-03-01
Primary completion
2025-12-01
Completion
2026-03-01
First posted
2025-02-28
Last updated
2025-02-28

Source: ClinicalTrials.gov record NCT06852001. Inclusion in this directory is not an endorsement.

Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases (NCT06852001) · Clinical Trials Directory